Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity (Q42272536)

19 October 2017

title

Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity (English)

1 reference

19 October 2017

1 reference

1 reference

F Assogna

0 references

C Hammer

0 references

H Ehrenreich

0 references

G Saher

0 references

S Papiol

0 references

A Schneider

0 references

B Stepniak

1 reference

19 October 2017

M Tantra

1 reference

19 October 2017

M Begemann

1 reference

19 October 2017

A-L Sirén

1 reference

19 October 2017

L A Pardo

1 reference

19 October 2017

S Sperling

1 reference

19 October 2017

S Mohd Jofrry

1 reference

19 October 2017

A Gurvich

1 reference

19 October 2017

N Jensen

1 reference

19 October 2017

K Ostmeier

1 reference

19 October 2017

F Lühder

1 reference

19 October 2017

C Probst

1 reference

19 October 2017

H Martens

1 reference

19 October 2017

M Gillis

1 reference

19 October 2017

G Spalletta

1 reference

19 October 2017

W Stöcker

1 reference

19 October 2017

T F Schulz

1 reference

19 October 2017

K-A Nave

1 reference

19 October 2017

language of work or name

English

0 references

publication date

3 September 2013

1 reference

19 October 2017

1 reference

19 October 2017

1 reference

19 October 2017

1 reference

19 October 2017

page(s)

1143-1149

1 reference

Memory and the NMDA receptors

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

Serum IgG antibodies against the NR1 subunit of the NMDA receptor not detected in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

Disease-relevant autoantibodies in first episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

A clinical and neurobiological case of IgM NMDA receptor antibody associated encephalitis mimicking bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encepha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

The cross-sectional GRAS sample: a comprehensive phenotypical data collection of schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

PLINK: a tool set for whole-genome association and population-based linkage analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

Impairment of the blood-nerve and blood-brain barriers in apolipoprotein e knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

Vulnerability of the developing brain to hypoxic-ischemic damage: contribution of the cerebral vasculature to injury and repair?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

Five years of GWAS discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

NMDA-induced neuronal survival is mediated through nuclear factor I-A in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

Infections and autoimmunity: the multifaceted relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

The initiation and prevention of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

N-methyl-D-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

A modern perspective on the differential diagnosis between encephalitis lethargica or anti-NMDA-receptor encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

Barriers in the developing brain and Neurotoxicology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

Psychosis: atypical limbic epilepsy versus limbic hyperexcitability with onset at puberty?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

Glutamate receptor dysfunction and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

Afferent facilitation of corticomotor responses is increased by IgGs of patients with NMDA-receptor antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: identification of subgroups with immune responses and blood-CSF barrier dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

Infections as triggers and complications of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

Systemic sclerosis and infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

Amantadine inhibits NMDA receptors by accelerating channel closure during channel block.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

Sex differences in the response to influenza virus infection: modulation by stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

Therapy of Pelizaeus-Merzbacher disease in mice by feeding a cholesterol-enriched diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.110

Effect of an NMDA receptor agonist on T-maze and passive avoidance test in 12-week streptozotocin-induced diabetic rats

21 January 2018

1 reference

12 December 2020

Apolipoprotein E controls cerebrovascular integrity via cyclophilin A.

1 reference

12 December 2020

Myasthenia Gravis: Passive Transfer from Man to Mouse

1 reference

12 December 2020

Characterisation of swabbing for virological analysis in the Spanish Influenza Sentinel Surveillance System during four influenza seasons in the period 2002-2006

1 reference

12 December 2020

Complexin2 null mutation requires a 'second hit' for induction of phenotypic changes relevant to schizophrenia.

1 reference

12 December 2020

Identifiers

DOI

10.1038/MP.2013.110

1 reference

Dimensions Publication ID

19 October 2017

1019862591

0 references

1 reference